Characterization of VLA‐4‐dependent myeloma cell adhesion to fibronectin and VCAM‐1
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The integrin VLA‐4 mediates attachment of myeloma cells to multiple myeloma (MM) bone marrow stroma. The alternatively‐spliced CS‐1 region of fibronectin (FN) and VCAM‐1 are main ligands for VLA‐4 and are both expressed on MM stroma. The H1 region is present in all FN isoforms and represents an additional binding site for VLA‐4. We employed FN fragments FN‐H89 and FN‐H0, that contain either the CS‐1 and H1, or only the H1 sites, respectively, as well as soluble VCAM‐1 (sVCAM‐1), to characterize VLA‐4‐mediated adhesion pathways used by myeloma cells to attach to MM stroma. CD38 high CD45RA− cells from MM bone marrow, and the myeloma‐derived cell lines NCI‐H929, IM‐9 and RPMI 8226, specifically adhered, by different degrees, to FN‐H89, FN‐H0 and sVCAM‐1, and their VLA‐4‐dependent adhesion was substantially up‐regulated by the anti‐β1 antibody TS2/16, which increases the affinity of VLA‐β1 integrins. Furthermore, VLA‐4 function on NCI‐H929 cells was enhanced by TS2/16 during adhesion to MM stroma. The α4β7 integrin mediated a small portion of myeloma cell line adhesion to FN‐H89, mainly upon integrin activation with Mn 2+. These results indicate that myeloma cells use VLA‐4 to interact with CS‐1/FN, H1/FN and VCAM‐1 on MM stroma, and that its function can be potentially up‐regulated, enabling higher degrees of cell adhesion to these VLA‐4 ligands, which might influence myeloma cell localization in the bone marrow.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633 · cited 1×
“IL-6 is a major cytokine implicated in the proliferation and survival in vitro of myeloma cells and plays an important role in vivo (Kawano et al, 1988; Klein et al, 1989, 1991).”
BackgroundChauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.3.1104.bloodjournal8731104 · Cited by 563
Cited by
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
García-Ortiz, A., Rodríguez-García, Y., Encinas, J., Maroto-Martín, E., Castellano, E., Teixidó, J., & Martínez-López, J. (2021) · Cancers · doi:10.3390/cancers13020217 · Cited by 238
Self-citationXu, S., Menu, E., Becker, A. D., Van Camp, B., Vanderkerken, K., & Van Riet, I. (2012) · Stem Cells · doi:10.1002/stem.787 · Cited by 103
Metadata
- Authors
- Sanz‐Rodríguez, F., Ruiz‐Velasco, N., Pascual‐Salcedo, D., & Teixidó, J.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 107
- Issue
- 4
- Pages
- 825-834
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1965428800
- Cited by
- 56
- References
- 2
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of VLA‐4‐dependent myeloma cell adhesion to fibronectin and VCAM‐1. https://app.cochat.ai/papers/10.1046/j.1365-2141.1999.01762.x
- The paper
- Sanz‐Rodríguez, F., Ruiz‐Velasco, N., Pascual‐Salcedo, D., & Teixidó, J. (1999). Characterization of VLA‐4‐dependent myeloma cell adhesion to fibronectin and VCAM‐1. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.1999.01762.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.